Home » Authors » Jim Shrine

Jim Shrine

Articles

ARTICLES

European Sector Rallying Cry: Comebacks, Consolidation

March 12, 2003

Companies Urged To Shore Up Until Sector Regains Favor

Sep. 11, 2002

Companies Urged To Shore Up Until Sector Regains Favor

Sep. 11, 2002

European Biotech Struggling, Industry Waiting For Upswing

Sep. 10, 2002

European Biotech Struggling, Industry Waiting For Upswing

Sep. 10, 2002

Finding Hot’ Biotech Investments Still Means Looking At Leaders

March 21, 2002

Finding Hot’ Biotech Investments Still Means Looking At Leaders

March 21, 2002

Investors In Tight Market Looking At Hybrid Platform/Product Firms

March 20, 2002

Investors In Tight Market Looking At Hybrid Platform/Product Firms

March 20, 2002

Large-Cap Companies Doing Well In Maturing Industry s Bifurcation

Jan. 1, 1999

View All Articles by Jim Shrine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for May 12, 2025.
AACR 2025: Induced proximity strategy, beyond degraders
BioWorld
Targeted protein degradation has yet to notch its first approval. But with more than two dozen agents now in clinical trials, the strategy’s ultimate clinical...
Navigating the Trump tariffs, part two: Amgen, Biogen, others
BioWorld
As biopharma companies continue to roll out their first-quarter earnings, Trump administration tariffs remain at the top of investors’ minds. While executives...
Little bite from voluntary most-favored nation Rx pricing order
BioWorld
After a week of hype, the most-favored nation (MFN) drug pricing executive order (EO) U.S. President Donald Trump signed May 12 has a lot of bark but little bite,...